The time has come for breast cancer risk assessment, counseling and genetic testing to move from cancer specialists to the realm of primary care. A growing body of evidence has documented the benefits of preventive measures for high-risk women including those with mutations in the BRCA1 and BRCA2 genes. Referral for cancer-risk assessment and BRCA testing in the primary care setting is a necessary step towards personalized medicine for women at risk.